| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Vice President | Executive Vice President
1 company
Ginascol John F is an Executive Vice President at ABBOTT LABORATORIES. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $12.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2022 | ABT Abbott Laboratories | Executive Vice President | Sell | 11,000 | $112.32 | $1,235,520.00 | -8.9% | |
| Mar 1, 2021 | ABT Abbott Laboratories | Executive Vice President | Sell | 365 | $118.16 | $43,128.47 | -0.3% | |
| Mar 1, 2021 | ABT Abbott Laboratories | Executive Vice President | Sell | 352 | $120.61 | $42,454.72 | -0.4% | |
| Apr 21, 2020 | ABT Abbott Laboratories | Executive Vice President | Sale+OE | 63,200 | $96.00 | $6,067,050.56 | -26.9% | |
| Mar 2, 2020 | ABT Abbott Laboratories | Executive Vice President | Sell | 6,606 | $77.63 | $512,805.34 | -4.6% |